SCHEMBL4367675

SCHEMBL4367675

COc1ccc(N(S)C(=O)NC(=O)COc2ccccc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.53
KMT2A Q03164 5/20 0.52
ALDH1A1 P00352 4/20 0.52
MAPT P10636 4/20 0.52
MEN1 O00255 4/20 0.52
KDM4E B2RXH2 2/20 0.52
LMNA P02545 2/20 0.52
HCAR2 Q8TDS4 1/20 0.50
NPC1 O15118 3/20 0.49
RAB9A P51151 3/20 0.49
POLB P06746 3/20 0.49
GAA P10253 2/20 0.49
CTDSP1 Q9GZU7 1/20 0.49
HPGD P15428 1/20 0.49
USP2 O75604 1/20 0.49
TSHR P16473 1/20 0.49
PKM P14618 1/20 0.49
HTT P42858 2/20 0.49
CYP1A2 P05177 1/20 0.48
CYP2C9 P11712 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4366082 0.88 NPC1 (0.56) PTPN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL4364688 0.87 NPC1 (0.51) KMT2AALDH1A1MAPTMEN1KDM4E
SCHEMBL4364701 0.86 KMT2A (0.51) KMT2AALDH1A1MAPTMEN1KDM4E
SCHEMBL5838481 0.86 MAPT (0.52) KMT2AALDH1A1MAPTMEN1KDM4E
SCHEMBL4370663 0.86 NPC1 (0.47) KMT2AALDH1A1MAPTMEN1KDM4E
SCHEMBL4375513 0.81 POLB (0.47) KMT2AALDH1A1MAPTLMNANPC1
SCHEMBL4363888 0.79 RAB9A (0.63) KMT2AMAPTMEN1KDM4ELMNA
SCHEMBL4367832 0.79 MEN1 (0.46) KMT2AALDH1A1MAPTMEN1LMNA
SCHEMBL4365796 0.78 NPC1 (0.42) KMT2AALDH1A1MEN1KDM4ELMNA
SCHEMBL4365410 0.76 ALDH1A1 (0.46) KMT2AALDH1A1MAPTMEN1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7476686-B2 Substituted aryl thioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS, INC. (US) 2009-01-13 US disclosed
US-7094807-B2 Substituted aryl thioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS, INC. (US) 2006-08-22 US disclosed
US-20060014836-A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication CHEN DAWEI 2006-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060014836-A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication NAT1, PIGS, SLC10A1 PTPN1 1196/4885KMT2A 1703/4885ALDH1A1 221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.